Your browser doesn't support javascript.
loading
Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune response.
Remic, Tinkara; Sersa, Gregor; Levpuscek, Kristina; Lampreht Tratar, Ursa; Ursic Valentinuzzi, Katja; Cör, Andrej; Kamensek, Urska.
Afiliação
  • Remic T; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Sersa G; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Levpuscek K; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Lampreht Tratar U; Faculty of Health Sciences, University of Ljubljana, Ljubljana, Slovenia.
  • Ursic Valentinuzzi K; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Cör A; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Kamensek U; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Front Immunol ; 13: 974912, 2022.
Article em En | MEDLINE | ID: mdl-36131926

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Melanoma Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Eslovênia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Melanoma Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Eslovênia